Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05846737
Status:
RECRUITING
Last Update Posted:
2023-05-06
First Post:
2023-04-27
Brief Title:
BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT
Sponsor:
Institute of Hematology Blood Diseases Hospital China
Organization:
Institute of Hematology Blood Diseases Hospital China
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma |
Keywords: